Clinical Pathways Search Results

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

This clinical pathway details the steps in identifying and managing children and adolescents who ingest toxic substances. It should be used in all cases of ingestion regardless of the child’s or adolescent’s intention.

This pathway guides the care of adolescents ≥ 12 years with suspected acute withdrawal from alcohol, benzodiazepine and/or opioid.

This pathway guides the diagnosis of Somatic Symptom and Related Disorders (SSRD) where the history/physical of a patient’s chief complaint does not align with known organic medical causes.

This pathway will guide the evaluation and treatment of a pediatric patient admitted with probable anti-NMDAR encephalitis

The Behavioral Concerns for the Child Undergoing EEG Monitoring Pathway is a detailed plan of the essential steps in treating a child in the inpatient and outpatient specialty care settings.

Inpatient Discharge Disposition Pathway provides guidance to patient who has an active Behavioral Health diagnosis or behaviors that are currently impacting their ability to successfully participate in medical care or impairing their ability to safely or successfully function in the community (home and/or school).

The inpatient anaphylaxis pathway takes a step-by-step approach to the evaluation and treatment of a child with a of history anaphylaxis.